Data from commercial health insurance (not workers compensation) includes that in 2024, about 34% of employers provided coverage for GLP-1 drugs for both diabetes and weight loss, up from 26% in 2023 (Employers Covering GLP-q Drugs in Health Plans Could Nearly Double in 2024, 2023)
Production declines with age
When commercially available, the projected retail price is $1,000 to $1,500 per month before insurance
Signs include rash, itching, swelling, dizziness, or difficulty breathing
Milk thistle and SAMe are generally well-tolerated in dogs with a wide margin of safety and no known side effects, although veterinary studies are limited
Transcriptional control of the human glucocorticoid receptor: identification and analysis of alternative promoter regions